LON:QP

Quantum Pharma Share Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average Volume446,328 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive QP News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Pharma and its competitors with MarketBeat's FREE daily newsletter.

About Quantum Pharma

Quantum Pharma Plc is a pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesaler, hospital and homecare markets. The Company's core business is the manufacture, procurement and supply of unlicensed medicines (specials) and special obtains to the United Kingdom pharmacy chains. It operates through three segments: Specials; Niche Pharmaceuticals (Niche), and Medication Adherence (MA). The Specials segment engages in the manufacture, source and supply specials to pharmacies, pharmaceutical wholesalers, hospitals, and other specials suppliers throughout the United Kingdom and overseas. The Niche Pharmaceuticals segment develops and supplies nice pharmaceuticals, provides development and regulatory services, and out-licenses products and dossiers to third parties across Europe. The Medication Adherence segment provides products and services designed to provide adherence to medication regimes.

LECLANCHE SA LECLANCHE ORD SHS (0QP6.L) stock forecast and price target
August 21, 2021 | finance.yahoo.com

Soccer-Messi back in training after joining PSG
August 12, 2021 | msn.com

Nuinsco Expands Ontario Gold Property Holdings with Option on Dash Lake Gold Project Near Fort Francis
March 21, 2021 | finance.yahoo.com

Nuinsco Resources Limited: Nuinsco Expands Ontario Gold Property Holdings with Option on Dash Lake Gold Project Near Fort Francis
March 19, 2021 | finanznachrichten.de

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolLON:QP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.quantumpharmaceuticalgro...
Phone+44-1207-279400
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Quantum Pharma.

4.7 Community Rank

Outperform Votes
Quantum Pharma has received 101 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Quantum Pharma has received 45 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Quantum Pharma has received 69.18% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Quantum Pharma and other stocks. Vote “Outperform” if you believe QP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe QP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Quantum Pharma does not currently pay a dividend.
Dividend Growth
Quantum Pharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Quantum Pharma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Quantum Pharma (LON:QP) Frequently Asked Questions

What stocks does MarketBeat like better than Quantum Pharma?

Wall Street analysts have given Quantum Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quantum Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Quantum Pharma's key executives?

Quantum Pharma's management team includes the following people:

Chris Rigg, Chief Executive Officer, Director
Gerard Thomas Murray, Chief Financial Officer, Director
George Liolios, Managing Director at Lamda
Brian Fisher, Joint Managing Director - Special Division
Nicola Massey, Managing Director - Niche Pharmaceuticals Division
Andrew Matthews, Joint Managing Director - Special Division
Ian Pearce, Managing Director - Medication Adherence Division
Craig Swinhoe, Group Legal and Projects Director and Company Secretary
Ian Roy Johnson, Non-Executive Chairman of the Board
Christopher Harwood Bernard Mills, Non-Executive Director

What other stocks do shareholders of Quantum Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quantum Pharma investors own include Europa Oil & Gas (EOG), Petroamerica Oil (PTA), Pearson (PSON), Paysafe Group (PAYS), Touchstone Innovations (IVO), GW Pharmaceuticals (GWPH), Futura Medical (FUM), Circassia Group (CIR), Condor Hospitality Trust (CDOR) and Cara Therapeutics (CARA).

What is Quantum Pharma's stock symbol?

Quantum Pharma trades on the London Stock Exchange (LON) under the ticker symbol "QP."

How do I buy shares of Quantum Pharma?

Shares of QP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Quantum Pharma's official website?

The official website for Quantum Pharma is www.quantumpharmaceuticalgro....

Where are Quantum Pharma's headquarters?

Quantum Pharma is headquartered at Quantum House Hobson Industrial Estate, Burnopfield, DURHAM, NE16 6EA, United Kingdom.

How can I contact Quantum Pharma?

Quantum Pharma's mailing address is Quantum House Hobson Industrial Estate, Burnopfield, DURHAM, NE16 6EA, United Kingdom. The company can be reached via phone at +44-1207-279400.

This page was last updated on 9/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.